TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/12/2025
Voltar para busca
Dado oficial do USPTO
SEPSIA THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 42
Data de depósito
26/10/2022
Data de registro
19/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/11/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
ES
Examinador
DAVIS, MARC STEPHEN
Unidade examinadora
N40
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the word "SEPSIA" in stylized capital letters, where the term "SEP" is in blue, and the term "SIA" is transparent appearing on a blue background in the form of a halved oblong shape. Below in stylized lowercase letters in blue is the wording "THERAPEUTICS". The color white represents background and is not a part of the mark.
Titulares e representantes
Titulares
SEPSIA THERAPEUTICS, S.L.
Representantes
Elizabeth Lee D'Amore Lucas & Mercanti, LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products namelypharmaceutical preparations for human and veterinary use for the treatment of infectious diseasesinflammatory conditionssepsisadvanced cell therapies and immunotherapy; biological preparations for medical and veterinary usebiological preparations for the treatment of infectious diseases; pharmaceuticalbiological and veterinary preparations for the treatment of infectious diseases and related inflammatory processesfor the treatment of sepsis and for advanced cell therapies and immunotherapy; pharmaceutical preparations containing nucleic acids and proteins and active peptides for medical and veterinary usepharmaceutical preparations containing nucleic acids and proteins and active peptides for the treatment of infectious diseases and related inflammatory processesfor the treatment of sepsis and for advanced cell therapies and immunotherapy
Classe 10
Medical machines for dialysishemoperfusion and hemoadsorption; medical devices for blood purificationhemoperfusion machines; medical adsorption devices and polymeric adsorption materials for the removal of materials from the blood or from blood fractions and kits primarily containing said testing devices for the identification of bacteria for medical use; electrical instruments for medical use in blood diagnostic analysis; assay instruments for medical diagnostic use in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for infectious diseases and associated inflammatory processessepsis and in advanced cell therapies and immunotherapy; medical diagnostic testing instruments for use in immunoassay procedures; diagnostic apparatus for medical use in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for infectious diseases and associated inflammatory processessepsis and in advanced cell therapies and immunotherapy; medical diagnostic testing apparatus for use in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for immunoassay procedures; apparatus and instruments for diagnostic testing for medical purposes in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for infectious diseases and associated inflammatory processessepsis and in advanced cell therapies and immunotherapy; apparatus and instruments for veterinary diagnosis in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for infectious diseases and associated inflammatory processessepsis and in advanced cell therapies and immunotherapy; medical diagnostic instruments for diagnosis in measuringtesting and analyzing bloodbody fluidscellsproteinspeptides and nucleic acids for infectious diseases and associated inflammatory processessepsis and in advanced cell therapies and immunotherapy; dialysis apparatusdialysis and hemofiltration machines; dialysis machines for veterinary usedialysis and hemofiltration machines; dialysis machines for medical use
Classe 42
Scientific and technological servicesas well as associated research and design servicesscientific research and development in the fields of biochemicalspharmacymedicine and veterinary medicine; industrial analysis services related to biologybiochemistrychemistrypharmacymedicine and veterinary medicineindustrial research in the fields of biologybiochemistrychemistrypharmacymedicine and veterinary medicine; scientific research services related to biologybiochemistrychemistrypharmacymedicine and veterinary medicine; scientific research services related to the treatment of infectious diseases and related inflammatory processessepsis and advanced cell therapies and immunotherapy; scientific research services related to peptides and proteins for pharmaceuticalmedical and veterinary use
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/12/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/05/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/04/2025
FIMP
FINAL DISPOSITION PROCESSED
14/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
19/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2024
PUBO
PUBLISHED FOR OPPOSITION
03/09/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
17/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/08/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/07/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/07/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
25/07/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/07/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
25/07/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/07/2024
RFNT
REFUSAL PROCESSED BY IB
26/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/02/2024
GNRT
NON-FINAL ACTION E-MAILED
25/02/2024
CNRT
NON-FINAL ACTION WRITTEN
25/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/01/2024
RFNT
REFUSAL PROCESSED BY IB
04/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/09/2023
RFRR
REFUSAL PROCESSED BY MPU
11/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/08/2023
CNRT
NON-FINAL ACTION WRITTEN
18/08/2023
DOCK
ASSIGNED TO EXAMINER
10/08/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SEPSIA THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.